Skip Content
You are currently on the new version of our website. Access the old version .
  • Review
  • Open Access

23 December 2017

Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus

,
,
,
,
,
and
1
National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA
2
Department of Biology, Arkansas University, Fayetteville, AR 72701, USA
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Endocrine Disruptors Leading to Obesity and Related Diseases

Abstract

Endocrine disrupting chemicals (EDCs) can mimic natural hormone to interact with receptors in the endocrine system and thus disrupt the functions of the endocrine system, raising concerns on the public health. In addition to disruption of the endocrine system, some EDCs have been found associated with many diseases such as breast cancer, prostate cancer, infertility, asthma, stroke, Alzheimer’s disease, obesity, and diabetes mellitus. EDCs that binding androgen receptor have been reported associated with diabetes mellitus in in vitro, animal, and clinical studies. In this review, we summarize the structural basis and interactions between androgen receptor and EDCs as well as the associations of various types of diabetes mellitus with the EDCs mediated through androgen receptor binding. We also discuss the perspective research for further understanding the impact and mechanisms of EDCs on the risk of diabetes mellitus.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.